Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 31, Number 1—January 2025
Synopsis

Cluster of Legionellosis Cases Associated with Manufacturing Process, South Carolina, USA, 2022

Hani M. Mohamed1Comments to Author , Lindsay Zielinski1, Abdoulaye Diedhiou2, Nakia Clemmons2, Jessica C. Smith, Jessica L. Rinsky, Troy Ritter, Melisa Willby, Nancy Burton, Karl Feldmann, Kevin Dunn, Rebecca Whisenhunt, Victoria Greer, Alberto M. Acosta, Mitchell Garber, Claressa E. Lucas, Kelley C. Henderson, Chris Edens, and Linda Bell
Author affiliation: South Carolina Department of Health and Environmental Control, Columbia, South Carolina, USA (H.M. Mohamed, A. Diedhiou, R. Whisenhunt, V. Greer, L. Bell); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (L. Zielinski, N. Clemmons, J.C. Smith, T. Ritter, M. Willby, C.E. Lucas, K.C Henderson, C. Edens); National Institute for Occupational Safety and Health, Cincinnati, Ohio, USA (J.L. Rinsky, N. Burton, K. Feldmann, K. Dunn); Weill Cornell College of Medicine, New York, New York, USA (A.M. Acosta); Engineering Systems Inc., Aurora, Illinois, USA (M. Garber)

Main Article

Figure 1

Classification of cases associated with a cluster of legionellosis in a manufacturing facility in South Carolina, USA, 2022. LTFU was defined as failure to reach a patient after 3 attempts within 1 week. Cases were excluded if either the case definition criteria were not met or if the patient had a clinically compatible illness and documentation of an alternative etiology or positive test for COVID-19 or influenza. LD, Legionnaires’ disease; LTFU, lost to follow-up.

Figure 1. Classification of cases associated with a cluster of legionellosis in a manufacturing facility in South Carolina, USA, 2022. LTFU was defined as failure to reach a patient after 3 attempts within 1 week. Cases were excluded if either the case definition criteria were not met or if the patient had a clinically compatible illness and documentation of an alternative etiology or positive test for COVID-19 or influenza. LD, Legionnaires’ disease; LTFU, lost to follow-up.

Main Article

1These first authors contributed equally to this article.

2These authors contributed equally to this article.

Page created: December 10, 2024
Page updated: December 19, 2024
Page reviewed: December 19, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external